Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy - Karacin, Cengiz; Oksuzoglu, Berna; Demirci, Ayse; Keskinkilic, Merve; Baytemur, Naziyet Kose; Yilmaz, Funda; Selvi, Oguzhan; Erdem, Dilek; Avsar, Esin; Paksoy, Nail; Demir, Necla; Goksu, Sema Sezgin; et al. (BMC, 2023)
Keywords: Advanced breast cancer; Cyclin\\-dependent kinase; Ribociclib; Palbociclib; Everolimus; Fulvestrant; Endocrine treatment; Hormonotherapy